RESUMO
The effect of therapy on renal function after unilateral nephrectomy for Wilms' tumour was studied. In the second year following unilateral nephrectomy, glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were estimated simultaneously by measuring 125I-iothalamate clearance and 131I-hippurate clearance. Of 41 evaluable patients, 29 received chemotherapy as sole treatment modality following nephrectomy (group 1); 12 patients additionally received radiation therapy to a field that included the remaining kidney (group 2). Results were expressed as standard deviation scores (z-scores). In group 1, mean z-score for GFR was -0.27 (94.6% of normal) and in group 2 mean z-score was -1.51 (72.7% of normal for two kidneys) (P = 0.022, Mann-Whitney U-test). Mean z-score for ERPF was -0.09 (97.0%) in group 1 and -1.53 (73.8%) in group 2 (P = 0.039). It was concluded that the combination of chemotherapy and radiation therapy, in contrast to chemotherapy alone, negatively affects the ability of the remaining kidney to adjust its function after the loss of its counterpart.
Assuntos
Neoplasias Renais/radioterapia , Rim/efeitos da radiação , Tumor de Wilms/radioterapia , Criança , Pré-Escolar , Terapia Combinada , Feminino , Taxa de Filtração Glomerular/efeitos da radiação , Humanos , Lactente , Rim/fisiologia , Neoplasias Renais/fisiopatologia , Neoplasias Renais/cirurgia , Masculino , Nefrectomia , Fluxo Plasmático Renal Efetivo , Tumor de Wilms/fisiopatologia , Tumor de Wilms/cirurgiaRESUMO
Deficiency of the enzyme glucose-6-phosphatase is the biochemical defect in glycogen storage disease type I (GSD I). Normally this enzyme is present in the liver, intestine and kidneys. The lack of the enzyme in the kidney makes it obvious that glycogen storage will not be restricted to the liver but that also the kidneys will be involved, possibly resulting in renal damage. Glycogen storage in the kidney is most outspoken present in the proximal tubular cells. In case of insufficient metabolic control, a Fanconi-like syndrome can develop, disappearing with improved therapy. Although renal disease has not been considered a problem in GSD I, recent findings indicate that especially in adult patients chronic renal disease is a common complication. In the past gout nephropathy and renal stones were the complications mentioned. Recently it appears that in a considerable number of patients after a period of 'silent' hyperfiltration, renal damage develops with proteinuria, hypertension and renal dysfunction later on. In biopsies of such patients focal glomerulosclerosis is found.
Assuntos
Doença de Depósito de Glicogênio Tipo I/complicações , Falência Renal Crônica/etiologia , Rim/patologia , Adolescente , Adulto , Biópsia , Síndrome de Fanconi/etiologia , Gota/etiologia , Humanos , Hipertrofia , Cálculos Renais/etiologia , Falência Renal Crônica/patologia , Pessoa de Meia-IdadeRESUMO
Renal failure has been reported recently as a late complication of glycogen storage disease type I (GSD I). We studied the renal function of 23 patients, mean age 10.9 years (range 2.2-21.6 years). The mean glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) were 188 +/- 50 and 927 +/- 292 ml/min per 1.73 m2, respectively (normal values for adult controls 90-145 and 327-697, respectively). Hyperfiltration (GFR greater than 145 ml/min per 1.73 m2) was found in 19 of 23 patients. There was no difference in GFR and ERPF between age groups 2-10 and 11-22 years. After a mean follow-up of 2.5 years (range 1-7.5 years) GFR and ERPF did not significantly change. At follow-up 3 patients (all older than 15 years) developed persistent glomerular proteinuria (0.1, 0.5 and 0.9 g/day). Besides a slight increase in fractional excretion of beta 2-microglobulin (FE-beta 2m) in 6 patients, proximal tubular function tests (FE-beta 2m, tubular reabsorption of phosphate and glucosuria) were normal. In patients with increased kidney length related to body height, GFR and ERPF were significantly higher than in patients with normal kidney length. We conclude that GSD I is characterised by hyperfiltration and hyperperfusion. The relative increment in kidney length is related to the degree of hyperfiltration.
Assuntos
Doença de Depósito de Glicogênio Tipo I/patologia , Doença de Depósito de Glicogênio Tipo I/fisiopatologia , Rim/patologia , Rim/fisiologia , Adolescente , Adulto , Estatura/fisiologia , Criança , Pré-Escolar , Feminino , Taxa de Filtração Glomerular/fisiologia , Doença de Depósito de Glicogênio Tipo I/urina , Humanos , Rim/irrigação sanguínea , Masculino , Tamanho do Órgão , Fluxo Sanguíneo Regional , Microglobulina beta-2/urinaRESUMO
UNLABELLED: From September 1989 until September 1993, stool specimens and sera from 113 children with diarrhoea-associated haemolytic uraemic syndrome (HUS) from the Netherlands, two university hospitals in Belgium and one university hospital in Germany were examined for the presence of verocytotoxin-producing Escherichia coli (VTEC) infection. Evidence for VTEC infection was observed in 88 (78%) patients with HUS compared to 2 (3%) of the 65 children with acute gastro-enteritis Serotype O157 was the causative agent in 76 (86%) of these 88 patients with VTEC-associated HUS and verocytotoxin-2 (VT-2) was the most frequent toxin produced. Serological testing for antibodies to O157 O-antigen yielded the highest number of positive results compared to the other test methods. Antibodies to O157 were found in sera of 71 (65%) of 110 patients with HUS and one control serum. Stool and sera examination for VTEC in 95 family contacts of 28 patients with HUS demonstrated an evidence for VTEC infection 33 (35%). In contrast, in patients with HUS serological antibodies to O157 O-antigen were found in only 3 (4%) of 85 family contacts. CONCLUSION: In this part of Western Europe, VT2-producing Escherichia coli, mainly those belonging to serogroup O157, are the major cause of HUS in childhood.
Assuntos
Toxinas Bacterianas/classificação , Infecções por Escherichia coli/complicações , Gastroenterite/complicações , Síndrome Hemolítico-Urêmica/epidemiologia , Bélgica/epidemiologia , Estudos de Casos e Controles , Criança , Pré-Escolar , Infecções por Escherichia coli/microbiologia , Feminino , Gastroenterite/microbiologia , Alemanha/epidemiologia , Humanos , Lactente , Masculino , Países Baixos/epidemiologia , Estudos Prospectivos , SorotipagemRESUMO
UNLABELLED: We describe the clinical symptoms and biochemical findings of a patient with succinyl-CoA:acetoacetate transferase deficiency who presented in the neonatal period and review the current literature on this subject. Our patient was initially suspected to have distal renal tubular acidosis, and subsequently, a fasting test revealed severe metabolic ketoacidosis with normal blood glucose after 13 h which suggest a defect in ketolysis. In his cultured skin fibroblasts succinyl-CoA:acetoacetate transferase was deficient (residual activity 15%). Treatment in the acute phase consisted of sodium bicarbonate. At the present age of 9 years, psychomotor and physical development are within normal limits. CONCLUSION: Defects of ketolysis probably are underdiagnosed disorders and should be considered in infants and young children with persistent ketosis.
Assuntos
Acetoacetatos/metabolismo , Acil Coenzima A/metabolismo , Coenzima A-Transferases/deficiência , Cetose/enzimologia , Erros Inatos do Metabolismo/enzimologia , Humanos , Lactente , Masculino , Erros Inatos do Metabolismo/diagnóstico , Erros Inatos do Metabolismo/terapiaRESUMO
The aim of the study was to investigate the effect of a protein restricted diet on renal function and growth of children with chronic renal failure. In a multicentre prospective study 56 children (aged 2-18 years) with chronic renal failure were randomly assigned to the protein restricted (0.8-1.1 g/kg/day) or the control group. All children were followed up by the same paediatrician and dietitian. After a follow up period of three years there was no significant difference in glomerular filtration rate between children on a protein restricted diet and children of the control group. There was no significant difference in weight with respect to height and height SD score between the protein restricted and the control group. Compliance with the protein restricted diet, as indicated by the prospective diet diaries and the serum urea:creatinine ratio, was good. This study shows that children with chronic renal failure do not benefit from a protein restricted diet.